National Guideline Clearinghouse | Lenalidomide in multiple myeloma.
October 14, 2013
Guideline Title
Lenalidomide in multiple myeloma.
Bibliographic Source(s)
| Chen C, Baldassarre F, Kanjeekal S, Herst J, Hicks L, Cheung M, Hematology Disease Site Group. Lenalidomide in multiple myeloma. Toronto (ON): Cancer Care Ontario (CCO); 2012 May 30. Various p. (Evidence-based series; no. 6-5). [86 references] |
Guideline Status
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines.
.png)
No hay comentarios:
Publicar un comentario